Oppenheimer Holdings Inc. Analysts Give K2M Group Holdings Inc (KTWO) a $26.00 Price Target

K2M Group Holdings Inc (NASDAQ:KTWO) has been given a $26.00 price target by equities research analysts at Oppenheimer Holdings Inc. in a research report issued to clients and investors on Wednesday, May 3rd. The firm presently has a “buy” rating on the medical device company’s stock. Oppenheimer Holdings Inc.’s price target would indicate a potential upside of 17.65% from the company’s previous close.

A number of other research firms have also issued reports on KTWO. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of K2M Group Holdings in a report on Tuesday, March 7th. Barclays PLC reaffirmed a “buy” rating and issued a $26.00 price objective on shares of K2M Group Holdings in a report on Wednesday, January 11th. Zacks Investment Research raised K2M Group Holdings from a “sell” rating to a “hold” rating in a report on Thursday, March 23rd. JMP Securities reaffirmed an “outperform” rating and issued a $27.00 price objective on shares of K2M Group Holdings in a report on Wednesday, April 12th. Finally, Cowen and Company reaffirmed an “outperform” rating and issued a $26.00 price objective (up previously from $21.00) on shares of K2M Group Holdings in a report on Sunday, April 9th. One analyst has rated the stock with a hold rating and nine have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $24.78.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

K2M Group Holdings (NASDAQ:KTWO) traded up 1.13% on Wednesday, reaching $22.35. The company’s stock had a trading volume of 193,514 shares. K2M Group Holdings has a 1-year low of $10.29 and a 1-year high of $23.92. The firm’s 50 day moving average price is $21.40 and its 200-day moving average price is $20.38. The company’s market capitalization is $951.13 million.

K2M Group Holdings (NASDAQ:KTWO) last released its quarterly earnings results on Tuesday, May 2nd. The medical device company reported ($0.26) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.24) by $0.02. K2M Group Holdings had a negative return on equity of 13.03% and a negative net margin of 16.45%. The company had revenue of $61.89 million for the quarter, compared to analysts’ expectations of $60.10 million. Equities analysts forecast that K2M Group Holdings will post ($0.80) earnings per share for the current year.

WARNING: “Oppenheimer Holdings Inc. Analysts Give K2M Group Holdings Inc (KTWO) a $26.00 Price Target” was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.chaffeybreeze.com/2017/05/19/k2m-group-holdings-inc-ktwo-given-a-26-00-price-target-by-oppenheimer-holdings-inc-analysts-updated.html.

Several hedge funds have recently made changes to their positions in KTWO. Legal & General Group Plc boosted its stake in shares of K2M Group Holdings by 9.1% in the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after buying an additional 564 shares in the last quarter. Simplex Trading LLC acquired a new stake in shares of K2M Group Holdings during the first quarter worth $187,000. Teton Advisors Inc. acquired a new stake in shares of K2M Group Holdings during the fourth quarter worth $200,000. Parkwood LLC acquired a new stake in shares of K2M Group Holdings during the first quarter worth $223,000. Finally, Paradigm Capital Management Inc. NY acquired a new stake in shares of K2M Group Holdings during the first quarter worth $226,000. 68.06% of the stock is owned by institutional investors.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

5 Day Chart for NASDAQ:KTWO

Receive News & Ratings for K2M Group Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply